MIT uncovers key blood protein

Scientists working in the only lab at MIT doing hematology research have uncovered a protein that plays a key role in the recycling of iron from blood.

Their work, described in the October 11 Journal of Clinical Investigation, could lead to new therapies for certain inherited blood disorders such as beta-thalassemia, a condition that causes chronic anemia. The team is led by Jane-Jane Chen, a principal research scientist in the Harvard-MIT Division of Health Sciences and Technology (HST).

Two years ago Chen and colleagues showed that a protein, heme-regulated eukaryotic translational initiation factor 2 ±-subunit (eIF2-alpha) kinase, or HRI for short, keeps mice with beta-thalassemia alive. This protein minimizes an abnormal and toxic imbalance of globin chains, the protein base for the hemoglobin found in red blood cells. Hemoglobin carries oxygen to our organs and carts away carbon dioxide waste.

In the new work, the team has found that HRI also plays a key role in the body's iron recycling process. Chen observed that this process falters in mice lacking HRI. As a result, less iron was available for use in the creation of new red blood cells.

A closer look revealed that HRI influences two mechanisms in this recycling process. First, a lack of HRI reduces levels of another protein called hepcidin. Hepcidin, recently discovered to be the master regulator of the iron cycle, releases iron from stores in the body and makes it available to be processed into hemoglobin. Without hepcidin, the body retains iron, but never puts it to work.

The team also found that HRI, which is expressed predominantly in the precursors of red blood cells, is expressed in macrophages. Macrophages are cells that literally reach out and grab dying red blood cells and eat them, digesting them and releasing the iron from their hemoglobin back into the system.

A lack of HRI causes these macrophages to lose their appetite, gobbling down fewer red blood cells. Instead of being digested and recycled, the red blood cells die and end up excreted through the kidneys. The result is a net loss of iron from the body.

With this new understanding of HRI's dual role in iron recycling-that it both keeps iron in the body and puts it to work-Chen is conducting a search for small molecules that might modulate the HRI signaling pathway. In turn, these compounds could potentially help diseased precursors of red blood cells survive and boost the iron recycling process.

“Perhaps we will find a compound that could help patients with beta-thelassemia or other diseases where HRI plays a role,” said Chen. Such conditions include a genetic disorder called erythropoietic protoporphyria (EPP), which causes photosensitivity and liver disease, as well as a condition called the anemia of inflammation in which the iron recycling process breaks down under the influence of stress, chronic disease, aging, or cancer.

Source: Massachusetts Institute of Technology

Related stories:

Mouse studies suggest daily dose of ginkgo may prevent brain cell damage after a stroke
Working with genetically engineered mice, researchers at Johns Hopkins have shown that daily doses of a standardized extract from the leaves of the ginkgo tree can prevent or reduce brain damage after an induced stroke.
Scientists simulate gut reaction to arsenic exposure
A simulated gastrointestinal system is helping scientists test contaminated soil for its potential to harm humans. The method is likely to save time and money for people hoping to repurpose land with an industrial past.
Racial differences for brain bleeds suggest stroke risk greater than thought for blacks
Small, clinically silent areas of bleeding in the brain appear to be more common in black versus white stroke patients hospitalized for new brain bleeds, say researchers at Georgetown University Medical Center. These findings may help explain the higher risk of hemorrhagic stroke among the black population, especially in those who are medically underserved.
Spate of Living Dead Flicks May Prove Dracula’s Lost his Bite
Are zombies the new vampires? Not exactly, but they could be the country’s monster crush du jour, says Texas Tech University pop-culture guru Rob Weiner.
Cutting calories could limit muscle wasting in later years
Chemical concoctions can smooth over wrinkles and hide those pesky grays, but what about the signs of aging that aren't so easy to fix, such as losing muscle mass? Cutting calories early could help, say University of Florida researchers who studied the phenomenon in rats.
Iron-moving malfunction may underlie neurodegenerative diseases, aging
A glitch in the ability to move iron around in cells may underlie a disease known as Type IV mucolipidosis (ML4) and the suite of symptoms—mental retardation, poor vision and diminished motor abilities—that accompany it, new research at the University of Michigan shows.
Researchers develop nano-sized 'cargo ships' to target and destroy tumors
Scientists have developed nanometer-sized 'cargo ships' that can sail throughout the body via the bloodstream without immediate detection from the body's immune radar system and ferry their cargo of anti-cancer drugs and markers into tumors that might otherwise go untreated or undetected.
Tracking down the menace in Mexico City smog
A new report by scientists who are part of the international MILAGRO Campaign indicates that some of the most harmful air pollution in Mexico City may not come from motor vehicles but instead originates with industrial sources – and that the culprit may be garbage incineration.

News discussion:

Medicine & Health news